OVID Ovid Therapeutics Inc.
$2.26▲ +4.87%
Healthcare
Other
After hours
$2.26▲ +0.00%
Oct 27, 4:01 PM ET
Volume 1.69M
Avg Volume (10D) 2.03M
Key Metrics & Fundamentals
Market Cap
$441.37M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.18 - 3.11
% vs 50 MA
-16.17%
% vs 200 MA
-8.18%
RSI-14
39.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.37
Free Cash Flow
-$17.59M
Gross Rev
$733,000
Gross Profit
$733,000
EBITDA
-$15.68M
COGS
–
Operating Exp
$16.43M
Operating Income
-$15.70M
EBIT
-$15.70M
Pretax Income
-$15.01M
Net Income
-$15.01M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
PR Newswire · Oct 15, 2026 7:30 AM ET
Ovid Therapeutics (OVID) Stock Gets Fair Value Boost As Analysts Focus On OV329
Simply Wall St. · Oct 8, 2026 5:13 AM ET
Guggenheim Initiates Ovid Therapeutics at Buy
MT Newswires · Oct 6, 2026 7:25 AM ET
Ovid Therapeutics (OVID) Cashes In One Bet To Fund Its Next Two
Insider Monkey · Sep 12, 2026 6:46 AM ET
Ovid Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 8:00 AM ET
What Makes Ovid Therapeutics (OVID) a Strong Momentum Stock: Buy Now?
Zacks · Aug 18, 2026 12:00 PM ET
Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
GlobeNewswire · Aug 13, 2026 8:30 AM ET
Outlook Therapeutics, Inc. (OTLK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks · Aug 6, 2026 10:00 AM ET
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 6, 2026 9:50 AM ET
Earnings Preview: Ovid Therapeutics (OVID) Q2 Earnings Expected to Decline
Zacks · Aug 5, 2026 10:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See OVID's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.